Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities
Por:
Abarca, Julio C., Huerta, Leonor, Fierro, Nora A.
Publicada:
1 mar 2020
Resumen:
The post antiretroviral therapy (ART) era for human immunodeficiency
virus (HIV) infection resulted in a dramatically increased proportion of
deaths attributed to liver-related causes in patients with HIV treated
with ART. Additionally, as patients become older as a result of
effective ART, liver-related conditions and application of safe
therapies are now major concerns in the setting of HIV infection. (C)
2020 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana,
S.L.U.
Filiaciones:
Abarca, Julio C.:
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico
Univ Nacl Autonoma Mexico, Biomed Res Inst, Dept Immunol, Mexico City, DF, Mexico
Huerta, Leonor:
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico
Univ Nacl Autonoma Mexico, Biomed Res Inst, Dept Immunol, Mexico City, DF, Mexico
Fierro, Nora A.:
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico
Univ Nacl Autonoma Mexico, Biomed Res Inst, Dept Immunol, Mexico City, DF, Mexico
|